| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |